Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus Morphology

被引:50
作者
Blumberg, Hilary P. [1 ,2 ]
Wang, Fei [2 ]
Chepenik, Lara G. [2 ]
Kalmar, Jessica H. [2 ]
Edmiston, Elliot Kale [2 ]
Duman, Ronald S.
Gelernter, Joel [2 ]
机构
[1] Yale Univ, Sch Med, Mood Disorders Res Program, Dept Psychiat, 300 George St,Suite 901, New Haven, CT 06511 USA
[2] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA
关键词
Hippocampus; magnetic resonance imaging; neurogenesis; single-nucleotide polymorphisms; vascular endothelial growth factor; voxel-based morphology;
D O I
10.1016/j.biopsych.2008.07.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Morphological abnormalities in hippocampus have been implicated in neuropsychiatric disorders, including depression, schizophrenia, and dementia. Vascular endothelial growth factor (VEGF) has been demonstrated to have neurogenic effects in the hippocampus in rats. However, influence of VEGF variation on hippocampus morphology in humans has yet to be shown. Here, an integrated genetic and neuroimaging approach was used to investigate whether VEGF variation influences hippocampus morphology in humans. Methods: High-resolution magnetic resonance imaging and voxel-based morphometry were used to identify the influence of genetic variation of VEGFA [rs833068 (SNP-1), rs833070 (SNP-2), rs2146323 (SNP-3) and rs3025020 (SNP-4)] on brain morphology in 47 healthy individuals. Results: Variation in VEGFA SNP-2 and SNP-3 showed significant effects on hippocampus concentration. Conclusions: The findings suggest that effects of VEGF in hippocampus found in rats extend to humans; further understanding of effects of VEGFA variation might have important implications in identifying individuals more vulnerable to hippocampus pathology as well as those neuropsychiatric populations most likely to benefit from VEGF-mediated interventions.
引用
收藏
页码:901 / 903
页数:3
相关论文
共 14 条
[11]   Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration [J].
Oosthuyse, B ;
Moons, L ;
Storkebaum, E ;
Beck, H ;
Nuyens, D ;
Brusselmans, K ;
Van Dorpe, J ;
Hellings, P ;
Gorselink, M ;
Heymans, S ;
Theilmeier, G ;
Dewerchin, M ;
Laudenbach, V ;
Vermylen, P ;
Raat, H ;
Acker, T ;
Vleminckx, V ;
Van den Bosch, L ;
Cashman, N ;
Fujisawa, H ;
Drost, MR ;
Sciot, R ;
Bruyninckx, F ;
Hicklin, DJ ;
Ince, C ;
Gressens, P ;
Lupu, F ;
Plate, KH ;
Robberecht, W ;
Herbert, JM ;
Collen, D ;
Carmeliet, P .
NATURE GENETICS, 2001, 28 (02) :131-138
[12]   Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study [J].
Tang, Yanqing ;
Wang, Fei ;
Xie, Guangrong ;
Liu, Jun ;
Li, Lehua ;
Su, Linyan ;
Liu, Ying ;
Hu, Xian ;
He, Zhong ;
Blumberg, Hilary P. .
PSYCHIATRY RESEARCH-NEUROIMAGING, 2007, 156 (01) :83-86
[13]  
TISCHER E, 1991, J BIOL CHEM, V266, P11947
[14]   VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants [J].
Warner-Schmidt, Jennifer L. ;
Duman, Ronald S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (11) :4647-4652